Literature DB >> 1958443

Evidence for pre-hepatic metabolism of oral cyclosporine in children.

K Hoppu1, O Koskimies, C Holmberg, E L Hirvisalo.   

Abstract

1. The pharmacokinetics of cyclosporine were investigated before renal transplantation in 20 children aged 1.1 to 16.8 years. Cyclosporine was given as a single oral dose (10 mg kg-1) or as a 4 h i.v. infusion (3 mg kg-1). 2. The blood drug concentration was measured by both specific and nonspecific monoclonal radioimmunoassays. 3. The mean oral availability of cyclosporine was 20.6% (range 10.8-34.1%). 4. The mean ratio of AUCs measured by nonspecific and specific r.i.a. was 1.96 (range 1.4-2.7) after oral administration and 1.43 (range 1.1-2.0) after i.v. administration. The mean difference between the ratios was 38.5% (P = 0.0001). The ratio of AUCnonspecific to AUCspecific was inversely related to blood drug clearance (r = 0.57; P = 0.009). 5. The findings are suggestive of presystemic, pre-hepatic metabolism of cyclosporine which could contribute to the low, and highly variable bioavailability of this drug.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958443      PMCID: PMC1368609          DOI: 10.1111/j.1365-2125.1991.tb03934.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects.

Authors:  J Grevel; E Nüesch; E Abisch; K Kutz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Biotransformation and distribution in blood of cyclosporine and its metabolites.

Authors:  G Maurer; M Lemaire
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

3.  Absorption of cyclosporine A after oral dosing.

Authors:  J Grevel
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

4.  Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine.

Authors:  B D Kahan; W G Kramer; C A Wideman; O H Frazier; M I Lorber; C Williams; S M Flechner; D A Cooley; C T Van Buren
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

5.  New automated high-performance liquid chromatographic analysis of cyclosporin A and G in human serum.

Authors:  P E Wallemacq; M Lesne
Journal:  J Chromatogr       Date:  1987-01-23

6.  Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.

Authors:  P B Watkins; S A Wrighton; E G Schuetz; D T Molowa; P S Guzelian
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 7.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

8.  Small-intestine length in infants and children.

Authors:  J R Siebert
Journal:  Am J Dis Child       Date:  1980-06

9.  Small-bowel length and the dose of cyclosporine in children after liver transplantation.

Authors:  P F Whitington; J C Emond; S H Whitington; C E Broelsch; A L Baker
Journal:  N Engl J Med       Date:  1990-03-15       Impact factor: 91.245

10.  Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dog.

Authors:  B Gridelli; L Scanlon; R Pellicci; R LaPointe; A DeWolf; H Seltman; W Diven; B Shaw; T Starzl; A Sanghvi
Journal:  Transplantation       Date:  1986-03       Impact factor: 4.939

  10 in total
  7 in total

Review 1.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 2.  Cyclosporin pharmacokinetics in paediatric transplant recipients.

Authors:  G F Cooney; K Habucky; K Hoppu
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.

Authors:  S Fanta; S Jönsson; J T Backman; M O Karlsson; K Hoppu
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

5.  Renal transplantation in children with emphasis on young patients.

Authors:  J Laine; C Holmberg; K Salmela; H Jalanko; H Sairanen; K Peltola; K Rönnholm; B Eklund; S Wikström; M Leijala
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

6.  Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted children.

Authors:  E Jacqz-Aigrain; C Montes; P Brun; C Loirat
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  Trough concentrations of cyclosporine in blood following administration with grapefruit juice.

Authors:  M P Ducharme; R Provenzano; M Dehoorne-Smith; D J Edwards
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.